SCHLAGWORTE: Impact Life Sciences
Now online: Impact Life Sciences 04/2025!
In the newest Impact Life Sciences Special, we explore current technology trends – this time with a focus on medical technology. Industry experts provide...
A golden era for drugs and devices
The global obesity crisis has evolved into one of the most significant healthcare
challenges of the 21st century. With over one billion people worldwide now...
‘What drives me is the vision to transform cancer care worldwide’
Theranostics, with its special subfield called radiotheranostics, is an innovative
approach that combines diagnostic imaging and targeted therapy using radionuclides to detect and treat cancer,...
Now online: The Impact Life Sciences Network
Our WHO IS WHO offers insight into the scene and its players, as well as initial guidance in your search for the right contacts...
Austria’s innovative life sciences scene: watch out for these companies, start-ups,...
Austria has earned an outstanding reputation as a research and production location in the life sciences – thanks to the synergy between top research...
All-in-one solution on offer
The medical technology company Luma Vision specialises in interventional cardiology procedures, offering cutting-edge hardware, software, and data science solutions for the treatment of cardiac...
‘A dating app for transplants’
Pirche develops AI-powered tools that personalise immunosuppression in transplantation medicine. Managing Director Tobias Klein explains how the platform is gaining clinical traction, why crowdfunding...
Biopesticides driving progress
Increasing resistance among pests and mounting regulatory requirements are placing growing pressure on agriculture. SenseUP Biotechnology offers an innovative, effective, and, above all, affordable...
Crowdfunding in the life sciences
Crowdfunding is a method of raising money to finance projects by collecting small contributions from a large number of people, typically via online platforms....
Patient communication is more than just bedside manners
Good healthcare has always relied on precise communication. But what happens when patients don’t understand the language spoken by the medical staff? In a...
Next-generation therapies
Ningaloo Biosystems’ technology enables the control of biological processes in living cells using light, thereby improving the productivity, quality, scalability, and reliability of pharmaceutical...
How big pharma companies rethink – and what start-ups can learn...
The patent cliff signifies the expiry of patent protection for major drugs, causing revenue drops as generics enter the market. Pharma companies face challenges...
Legal pathways through the valley of death
A major challenge for companies in life sciences is to live through the long years of turning innovation into clinical studies and subsequently into...
Biotech boom in Switzerland
The biotech sector is powering a strong first half year for the Swiss venture capital market. With CHF 705 million in invested capital, the...
Europe invests billions – but where are the scaled start-ups?
European countries, especially Germany, invest billions annually in basic and translational research. The scientific quality is high, the researchers are world-class, and the infrastructure...